Microbiome role in pancreatic diseases development
https://doi.org/10.22416/1382-4376-2017-27-3-11-17
Abstract
Aim of review. To present the modern concept on the mechanisms of pancreatic disease development and role of intestinal and oral microbiome in pancreatitis pathogenesis. Summary. Intestinal barrier dysfunction, bacterial overgrowth syndrome and endotoxinemia are features of acute pancreatitis. Image-recognition systems (toll-like and NOD-like receptors) and microorganism-associated molecular patterns play important role in these processes. Obtained data indicate the presence of oral and gastrointestinal microbial changes at pancreatic diseases. Subsequently,Helicobacterpyloriinfection may play a role in development of autoimmune pancreatitis and pancreatic cancer,PorphyromonasgingivalisandAggregatibacteractinomycetemcomitans- in pancreatic cancer development. Conclusion. Original study results indicate the presence of oral and bowel microbial changes in pancreatic diseases. Taking into account the ability of probiotics to stimulate production of antimicrobial peptides, normalize epithelial barrier function, limit bacterial translocation, their the application may be promising for pancreatic diseases treatment.
About the Authors
Yu. V. Evsyutina
Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University
Russian Federation
Russian Federation
V. T. Ivashkin
Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University
Russian Federation
Russian Federation
References
1. BlaserM.J.The microbiome revolution. J Clin Invest 2014; 124(10):4162-5.
2. BelkaidY.,HandT.W.Role of the microbiota in immunity and inflammation. Cell 2014; 157(1):121-41.
3. HiltyM.,BurkeC.,PedroH.et al. Disordered microbial communities in asthm atic airways. PLoS One 2010; 5(1):e8578.
4. RedinboM.R.The microbiota, chemical symbiosis, and human disease. J Mol Biol 2014; 426(23):3877-91.
5. OchiA.,GraffeoC.S.,ZambirinisC.P.et al. Toll-like receptor 7 regulates pancreatic carcinogenesis in mice and humans. J Clin Invest 2012; 122(11):4118-29.
6. OchiA.,NguyenA.H.,BedrosianA.S.et al. MyD88 inhibition amplifies dendritic cell capacity to promote pancreatic carcinogenesis via Th2 cells. J Exp Med 2012; 209(9):1671-87.
7. HoqueR.,SohailM.,MalikA.et al. TLR9 and the NLRP3 inflammasome link acinar cell death with inflammation in acute pancreatitis. Gastroenterology 2011; 141(1):358-69.
8. TsujiY.,WatanabeT.,KudoM.et al. Sensing of commensal organisms by the intracellular sensor nod1 mediates experimental pancreatitis. Immunity 2012; 37(2):326-38.
9. KawasakiT.,KawaiT.Toll-like receptor signaling pathways. Front Immunol 2014; 5:1-6.
10. MiyaraM.,SakaguchiS.Human FoxP3+CD4+ regulatory T cells: their knowns and unknowns. Immunol Cell Biol 2011; 89(3):346-51.
11. BlaserM.J.Equilibria of humans and our indigenous microbiota affecting asthma. Proc Am Thorac Soc 2012; 9(2):69-71.
12. ChenY.,BlaserM.J.Inverse associations of Helicobacter pylori with asthma and allergy. Arch Intern Med 2007; 167(8):821-7.
13. ReibmanJ.,MarmorM.,FilnerJ.et al. Asthma is inversely associated with Helicobacter pylori status in an urban population. PLoS ONE 2008; 3(12):e4060.
14. ArnoldI.C.,DehzadN.,ReuterS.et al. Helicobacter pylori infection prevents allergic asthma in mouse models through the induction of regulatory T cells. J Clin Invest 2011; 121(8):3088-93.
15. LealLopesC.,VellosoF.J.,CampopianoJ.C.et al. Roles of Commensal Microbiota in Pancreas Homeostasis and Pancreatic Pathologies. J Diabet Res 2015; 2015:1-19.
16. YadavD.,LowenfelsA.B.He epidemiology of pancreatitis and pancreatic cancer. Gastroenterology 2013; 44(6):1252-61.
17. LiuH.,LiX.W.,WangLiJ.,WYu. Early gut mucosal dysfunction in patients with acute pancreatitis. Pancreas 2008; 36(2):192-6.
18. HoqueR.,MalikA.F.,GorelickF.,MehalW.Z.Sterile inflammatory response in acute pancreatitis. Pancreas 2012; 41(3):353-7.
19. KocsisА.K.,SzabolcsA.,HofnerP.et al. Plasma concentrations of high-mobility group box protein 1, soluble receptor for advanced glycation end-products and circulating DNA in patients with acute pancreatitis.Pancreatology 2009; 9(4):383-91.
20. SongJ.M.,LiuH.-X.,LiY.et al. Extracellular heatshock protein 70 aggravates cerulein-induced pancreatitis through toll-like receptor-4 in mice. Chin Med J 2008; 121(15):1420-5.
21. DingS.Q.,LiY.,ZhouZ.G.et al. Toll-like receptor 4-mediated apoptosis of pancreatic cells in ceruleininduced acute pancreatitis in mice. Hepatobil Pancreat Dis Intern 2010; 9(6):645-50.
22. NishioA.,AsadaM.,UchidaK.et al. The role of innate immunity in the pathogenesis of experimental autoimmune pancreatitis in mice. Pancreas 2011; 40(1):95-102
23. WereszczynskaSiemiatkowskaU.,MroczkoB.,Siemiatkowski A.Serum profiles of interleukin-18 in different severity forms of human acute pancreatitis.Scand J Gastroenterol 2002; 37(9):1097-102.
24. UedaT.,TakeyamaY.,YasudaT.et al. Significant elevation of serum interleukin-18 levels in patients with acute pancreatitis. J Gastroenterol 2006; 41(2):158-65.
25. GuarneriF.,GuarneriC.,BenvengaS.Helicobacter pylori and autoimmune pancreatitis: role of carbonic anhydrase via molecular mimicry? J Cell Mol Med 2005; 9(3):741-4.
26. HarutaI.,YanagisawaN.,KawamuraS.et al. A mouse model of autoimmune pancreatitis with salivary gland involvement triggered by innate immunity via persistent exposure to avirulent bacteria. Lab Invest 2010; 90(12):1757-69.
27. DingJ.L.,ZhouZ.G.,ZhouX.Y.et al. Attenuation of acute pancreatitis by peroxisome proliferator-activated receptor-α in rats: the effect on toll-like receptor signaling pathways. Pancreas 2013; 42(1):114-22.
28. HoqueR.,FarooqA.,GhaniA., Gorelick F,MehalW.Z.Lactate reduces liver and pancreatic injury in tolllike receptorand inflammasome-mediated inflammation via gpr81-mediated suppression of innate immunity. Gastroenterology 2014; 146(7):763-4.
29. GorskiiV.A.,AgapovM.A.,KhorevaM.V.et al. Effect of lornoxicam therapy on expression of TLR2 and TLR4 mRNA during systemic complications of acute pancreatitis. Bull Exp Biol Med 2014; 158(1):13-5.
30. Kotelnikov A.G., Patyutko Yu.I., Tryakin A.A. Diagnosis and treatment of pancreatic malignancies: clinical guidelines. M.; 2014. 44 p.
31. ZeniL.B.,RussiR.F.,FialhoA.F.et al. Morbidity and mortality of pancreatic tumors undergoing surgical treatment. Arq Brasil Cir Dig 2014; 27(4):275-9.
32. SohalD.P.,ShrotriyaS.,GlassK.T.et al. Predicting early mortality in resectable pancreatic adenocarcinoma: a cohort study. Cancer 2015; 121(11):1779-84.
33. KunduY.L.,SeowS.W.Gut microbiota accelerate tumor growth via c-jun and STAT3 phosphorylation in APCMin/+ mice. Carcinogenesis 2012; 33(6):1231-8.
34. SchwabeR.F.,JobinC.The microbiome and cancer. Nat Rev Cancer 2013; 13(11):800-12.
35. FarrellJ.J.,ZhangL.,ZhouH.et al. Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer. Gut 2012; 61(4):582-8.
36. MichaudD.S.,IzardJ.Microbiota, Oral Microbiome, and Pancreatic Cancer. Cancer J 2014; 20(3): 203-6.
37. MichaudD.S.,IzardJ.,WilhelmBenartziC.S.et al. Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study.Gut 2012; 62:1764-70.
38. TorresP.J.,FletcherE.M.,GibbonsS.M.et al. Characterization of the salivary microbiome in patients with pancreatic cancer. Peer J 2015; 5;3:e1373.
39. YamanakaN.,MorisakiT.,NakashimaH.et al. nterleukin 1β enhances invasive ability of gastric carcinoma through nuclear factor-κB activation. Clin Cancer Res 2004; 10(5):1853-9.
40. VanMinnenL.P.,NieuwenhuijsV.B., deBruijnM.T.et al. Effects of subtotal colectomy on bacterial translocation during experimental acute pancreatitis. Pancreas 2006; 32:110-4.
41. ShanmiaoG.,ZhiyongY.,TaoL.et al.Use of probiotics in the treatment of severe acute pancreatitis: a systematic review and meta-analysis of randomized controlled trials.Crit Care 2014; 18(2):R57.
42. MadsenK.L.Enhancement of epithelial barrier function by probiotics. J Epithel Biol Pharmacol 2012; 5:55-9.
43. SmithA.R.,MacfarlaneG.T.,ReynoldsN.et al. Effect of a synbiotic on microbial community structure in a continuous culture model of the gastric microbiota in enteral nutrition patients. FEMS Microbiol Ecol 2012; 80:135-45.
Review
For citations:
Evsyutina Yu.V., Ivashkin V.T. Microbiome role in pancreatic diseases development. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2017;27(3):11-17. (In Russ.) https://doi.org/10.22416/1382-4376-2017-27-3-11-17
Views:
1057
Email this article 
